Literature DB >> 2386383

Serum immunoglobulins to endotoxin core glycolipid: establishment of normal concentrations.

S K Jackson1, J Parton, G Shortland, J M Stark, E N Thompson.   

Abstract

Serum antibody to lipopolysaccharide core glycolipid was measured in normal children and in full term and premature (less than or equal to 1500 g) infants. Antilipopolysaccharide core glycolipid antibody was present in term infants and normal children, and reached adult titres by 15 years of age. The specific anti core glycolipid antibody was predominately of the IgG class. Preterm infants (less than 32 weeks' gestation) had significantly lower titres of antilipopolysaccharide core glycolipid than more mature preterm or term infants. The results suggest that administration of anticore glycolipid immunoglobulin may be beneficial in the treatment or prevention of Gram negative septicaemia in preterm and very young infants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386383      PMCID: PMC1792452          DOI: 10.1136/adc.65.7.768

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Development of the premature infant's host defense system and its relationship to routine immunizations.

Authors:  J Bernbaum; R Anolik; R A Polin; S D Douglas
Journal:  Clin Perinatol       Date:  1984-02       Impact factor: 3.430

2.  A half century of neonatal sepsis at Yale: 1928 to 1978.

Authors:  R M Freedman; D L Ingram; I Gross; R A Ehrenkranz; J B Warshaw; R S Baltimore
Journal:  Am J Dis Child       Date:  1981-02

3.  Normal values of immunoglobulins in premature and in full-term infants, calculated as percentiles.

Authors:  U Pilgrim; H P Fontanellaz; G Evers; W H Hitzig
Journal:  Helv Paediatr Acta       Date:  1975-07

4.  Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.

Authors:  J L Shenep; K A Mogan
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

Review 5.  Immunotherapy of neonatal septicemia.

Authors:  M C Yoder; R A Polin
Journal:  Pediatr Clin North Am       Date:  1986-06       Impact factor: 3.278

6.  Early and late neonatal septicaemia.

Authors:  M M Placzek; A Whitelaw
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

7.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

Authors:  E J Ziegler; J A McCutchan; J Fierer; M P Glauser; J C Sadoff; H Douglas; A I Braude
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

8.  Increasing incidence of neonatal septicemia: causative organism and predisposing risk factors.

Authors:  R Bennet; M Eriksson; R Zetterström
Journal:  Acta Paediatr Scand       Date:  1981-03

9.  Thirty years of supplying the missing link. History of gamma globulin therapy for immunodeficient states.

Authors:  J M Dwyer
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

10.  Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides.

Authors:  S Izui; R A Eisenberg; F J Dixon
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  2 in total

1.  Serum immunoglobulins in acute lymphoblastic leukaemia.

Authors:  M M Reid
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

2.  Serum immunoglobulins to endotoxin core glycolipid: acute leukaemia and other cancers.

Authors:  S K Jackson; J Parton; G Shortland; J M Stark; E N Thompson
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.